Listen Score
LS 35
Global Rank
TOP 3%

ABOUT THIS PODCAST 🔗

Update frequency:
weekly
Average audio length:
74 minutes
Guest interviews
English
United States
98 episodes
since Nov. 26, 2019
episodic
explicit content

AUDIENCE OF THIS PODCAST 🔗

~47.52% of listeners are from United States.
🇺🇸
US
47.52%
🇨🇦
CA
8.81%
🇳🇱
NL
7.85%
🇬🇧
GB
7.71%
🇩🇪
DE
5.23%
🇧🇪
BE
2.89%
🇦🇹
AT
2.34%
🇷🇺
RU
1.92%
🇳🇴
NO
1.79%
🇦🇺
AU
1.65%
🇫🇷
FR
1.51%
🇩🇰
DK
0.96%
🇯🇵
JP
0.82%
🇮🇳
IN
0.68%
🇨🇴
CO
0.68%
🇮🇪
IE
0.68%
🇨🇭
CH
0.55%
🇫🇮
FI
0.55%
🇹🇭
TH
0.55%
🇸🇪
SE
0.41%
🇪🇸
ES
0.41%
🇳🇿
NZ
0.41%
🧅
T1
0.27%
🇨🇳
CN
0.27%
🇯🇲
JM
0.27%
🇧🇧
BB
0.27%
🇿🇦
ZA
0.27%
🇸🇮
SI
0.27%
🇦🇷
AR
0.27%
🇸🇦
SA
0.27%
🇸🇰
SK
0.27%
🇷🇴
RO
0.27%
🇮🇹
IT
0.13%
🇧🇷
BR
0.13%
🇵🇱
PL
0.13%
🇲🇾
MY
0.13%
🇨🇿
CZ
0.13%
🇦🇪
AE
0.13%
🇭🇰
HK
0.13%
🇹🇷
TR
0.13%
🇰🇪
KE
0.13%
Others
0.21%
* Data source: directly measured on Listen Notes. real-time

LATEST EPISODE 🔗

Normie, Mike, and Neşe discuss the upcoming MAHA Summit and its psychedelic pharmaceutical sponsors.

SEARCH PAST EPISODES

Search past episodes of The Psymposia Podcast.

PREVIOUS EPISODES

The crew discusses the FDA's September 14 psychedelic hearing, including Neşe's experience being in attendance, the financial conflicts of interest at the event, and the pseudoscientific beliefs of practitioners who gave testimony. Footnotes: Submit written comment to the FDA by October 5, 2026 h…
Psymposia dives into the recent Rolling Stone article — "Reggie Watts Is a Prominent Ketamine Advocate. Was It His Ex's 'Undoing'?" — and explores how the dynamics at play in that article are pervasive within the psychedelic advocacy scene. Footnotes: Reggie Watts Is a Prominent Ketamine Advocat…
Psymposia interviews YouTube documentarian @Alex-Novell about his experience with Andrew Callaghan and Channel 5, drug legalization, and creating documentary films. Thumbnail terminator image provided by Alex Novell.
Psymposia discusses takeaways from their "Psychedelic Conversion Therapy" series and reflects on the ten year anniversary of their "Coming Out of the Psychedelic Closet" series.
The crew discusses two recent news stories — a recently published New Yorker article on right-wing psychedelia and the news that Resilient Pharmaceuticals resubmitted its MDMA for PTSD application without the new Phase 3 study that was requested during its 2024 rejection. We have an interview Zena…
Neşe and Russell speak with Kaleb Graves about his reporting on the growing links between psychedelic therapy and conversion therapy movements. Drawing from his article — "Psychedelic Conversion Therapy: How Christian Nationalism Is Co-Opting a Movement Once Reserved for Hippies" — they discuss how…
Neşe and Russell examine the rise of modern right-wing influencers who simultaneously advocate for the dismantling of "woke" ideologies, express support for conversion therapy frameworks, and promote the use of psychedelic therapy. Focusing on figures like Elon Musk and Jordan Peterson, they explor…
Neşe and Russell review the history and harms of conversion therapy practices in the broader medical landscape, as well as their persistence throughout the history of psychedelic research. In the first wave of psychedelic science, influential figures helped legitimize deeply harmful ideas about pha…
The crew discusses AtaiBeckley's acquisition by Eli Lilly, The Wall Street Journal's mini-documentary on 5-MeO-DMT, and a recent death that occurred during a psychedelic retreat.
Disclaimer: The podcast and artwork embedded on this page are from Psymposia, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.